StonvexLoading…
StonvexStonvexStonvexCore line items from RMAX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $291.60M | $307.69M | $325.67M | $353.39M |
Operating Income | $47.04M | $40.18M | $-10.64M | $38.21M |
Net Income | $13.43M | $8.08M | $-98.49M | $10.76M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $582.48M | $581.59M | $577.15M | $695.23M |
Total Liabilities | $611.46M | $639.99M | $653.21M | $663.53M |
Cash & Equivalents | $118.74M | $96.62M | $82.62M | $108.66M |
Free Cash Flow OCF − CapEx | $33.50M | $53.03M | $21.84M | $61.21M |
Shares Outstanding | Not available | Not available | Not available | Not available |